SCHEMBL10195108

SCHEMBL10195108

CCc1ccc(Oc2ccc(Cl)cc2)cc1C1=C(O)CCCC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTR2A P28223 2/20 0.34
SLC6A4 P31645 2/20 0.34
KCNH2 Q12809 2/20 0.34
HPD P32754 3/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
S1PR5 Q9H228 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
MMP14 P50281 1/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10196155 0.93 MAOA (0.39) MAOAMAOBALDH1A1LMNAHTR2A
SCHEMBL10195133 0.88 MAOB (0.40) MAOAMAOBALDH1A1LMNAKDM4E
SCHEMBL10195110 0.88 MAOA (0.39) MAOAMAOBALDH1A1HPDMAPT
SCHEMBL10195126 0.88 HTR2A (0.41) MAOAMAOBLMNAHTR2ASLC6A4
SCHEMBL10195170 0.86 HTR2A (0.38) MAOAMAOBALDH1A1HTR2ASLC6A4
SCHEMBL10194939 0.86 SLC6A4 (0.41) MAOAMAOBLMNAHTR2ASLC6A4
SCHEMBL11940679 0.84 HSD17B1 (0.39) MAOAMAOBALDH1A1LMNAKDM4E
SCHEMBL516287 0.83 MAOB (0.36) MAOAMAOBALDH1A1LMNAHTR2A
SCHEMBL10196025 0.82 HSP90AA1 (0.41) HTR2ASLC6A4KCNH2
SCHEMBL10195127 0.82 SLC6A4 (0.42) HTR2ASLC6A4KCNH2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAOA 1359/4885MAOB 1215/4885ALDH1A1 45/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAOA 2359/4885MAOB 2064/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.